During the past decade, BCS Heart, LLP conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "BCS Heart, LLP" are "Bradycardia" (1 trials), "Optim Lead Insulation Related Adverse Events" (1 trials) and "Superficial Femoral Artery Stenosis" (1 trials). Many other conditions were trialed in "BCS Heart, LLP" in a lesser frequency.

Most popular intervention types in "BCS Heart, LLP" are "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "PTA followed by placement of LifeStent® Vascular Stent" (1 trials) and "St. Jude Medical Tendril MRI™ lead" (1 trials). Other intervention names were less common.

The vast majority of trials in "BCS Heart, LLP" are 3 trials for "All" genders.

Currently, there are NaN active trials in "BCS Heart, LLP". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in BCS Heart, LLP, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in BCS Heart, LLP, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".